NCT07416136

Brief Summary

This study aims to compare the effects of two commonly used topical mouth sprays on pain, swelling, and limitation of mouth opening after surgical removal of impacted lower wisdom teeth. A total of 40 adult patients who require the removal of both lower impacted wisdom teeth will participate in this study. Each patient will undergo two separate surgical procedures, with a healing period between them. After each surgery, one of the two topical agents will be applied to the surgical area. The order of the treatments will be randomly assigned. The study is designed so that neither the patients nor the clinician evaluating the outcomes will know which topical agent is used at each session. Pain levels, facial swelling, and mouth opening will be measured at specific time points after surgery. The results will help determine whether one topical treatment is more effective than the other in reducing postoperative discomfort and improving recovery. The information obtained from this study may contribute to improving postoperative care following wisdom tooth surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 19, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 17, 2026

Completed
Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

February 8, 2026

Last Update Submit

March 21, 2026

Conditions

Keywords

wisdom tooth surgerypostoperative morbiditychlorhexidinebenzydamineflurbiprofensplit-mouth study

Outcome Measures

Primary Outcomes (3)

  • Postoperative pain intensity assessed by Visual Analog Scale (VAS)

    Postoperative pain intensity assessed by the Visual Analog Scale (VAS, 0-10 cm), where 0 indicates no pain and 10 indicates worst imaginable pain; higher scores indicate greater pain intensity.

    From 30 minutes to 168 hours after surgery

  • Postoperative facial swelling measurements

    Postoperative facial swelling measured by linear facial distances (in centimeters) including tragus to pogonion, tragus to labial commissure, and mandibular angle to lateral canthus; higher values indicate greater swelling.

    Preoperatively, postoperative day 2 and postoperative day 7

  • Maximum mouth opening (trismus assessment)

    Trismus will be evaluated by measuring the maximum interincisal distance between the upper and lower central incisors using a ruler.

    Preoperatively, postoperative day 2 and postoperative day 7

Secondary Outcomes (1)

  • Postoperative analgesic consumption

    From the day of surgery to postoperative day 7

Study Arms (2)

Kloroben Topical Spray Group

EXPERIMENTAL

Following surgical extraction of the impacted mandibular third molar, Kloroben topical spray containing chlorhexidine gluconate and benzydamine hydrochloride is applied to the surgical site. Patients use the spray postoperatively according to the study protocol, and postoperative pain, swelling, and trismus are evaluated.

Drug: Klorhex Plus topical spray

Klorhex Plus Topical Spray Group

ACTIVE COMPARATOR

Following surgical extraction of the impacted mandibular third molar, Klorhex Plus topical spray containing chlorhexidine gluconate and flurbiprofen is applied to the surgical site. Patients use the spray postoperatively according to the study protocol, and postoperative pain, swelling, and trismus are evaluated.

Drug: Kloroben topical spray

Interventions

Kloroben topical spray containing chlorhexidine gluconate and benzydamine hydrochloride is applied to the surgical site immediately after impacted mandibular third molar extraction and used postoperatively according to the study protocol to reduce pain, swelling, and trismus.

Klorhex Plus Topical Spray Group

Klorhex Plus topical spray containing chlorhexidine gluconate and flurbiprofen is applied to the surgical site immediately after impacted mandibular third molar extraction and used postoperatively according to the study protocol to reduce pain, swelling, and trismus.

Kloroben Topical Spray Group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adults aged between 18 and 50 years
  • Indication for bilateral impacted mandibular third molar extraction
  • ASA physical status I or II
  • No antibiotic use within the previous two weeks
  • No analgesic use within the previous 12 hours
  • Ability to provide written informed consent

You may not qualify if:

  • ASA physical status III to V
  • Pregnancy or breastfeeding
  • Known allergy to chlorhexidine, benzydamine, or flurbiprofen
  • Smoking more than one pack per day
  • History of substance abuse
  • Presence of systemic diseases that may affect wound healing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara Unıversity Faculty of Dentistry

Istanbul, Maltepe, 34840, Turkey (Türkiye)

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Monitor Clinician
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: This is a randomized, double-blind, crossover (split-mouth) clinical trial. Each participant undergoes two separate surgical procedures for bilateral impacted mandibular third molar extraction. After each procedure, a different topical agent is applied in a randomized order, with a healing period between interventions. Outcomes are compared within the same participant to minimize inter-individual variability.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

February 8, 2026

First Posted

February 17, 2026

Study Start

April 20, 2025

Primary Completion

August 15, 2025

Study Completion

October 19, 2025

Last Updated

March 25, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to patient confidentiality, institutional policies, and local ethical regulations.

Locations